Sinovac Biotech said its inactivated hepatitis A vaccine has won an exclusive public sector supply contract in Oman for 2026 and 2027, marking its first breakthrough in the Gulf Cooperation Council ...

(Yicai) Jan. 23 -- Sinovac Biotech has won the exclusive contract to supply Oman’s national immunization program with the Chinese pharmaceutical giant’s inactivated hepatitis A vaccine, called Healive ...

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, ...

1Globe is led by Chiang Li and serves as an umbrella for his portfolio of life-science companies. Chiang Li represents a ...

Prime Success, L.P. (together with its affiliates, “Prime Success” or “we”), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), continues to be disappointed ...

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, ...

Corrects the Company’s Misrepresentations of Vivo’s Capital Contributions, Which Have Been Critical to Sinovac’s Commercial Success and Ability to Return Capital to Shareholders Calls on All ...

SAIF Nominees Will Work to Resolve Costly Legal Battles, Take Action to Resume Stock Trading after Six-Year Halt, and Facilitate Distribution of Cash That Rightfully Belongs to Shareholders Urges ...

BEIJING, Sept 24 (Reuters) - China's Sinovac Biotech expects to begin analysing final-stage human trial data on its coronavirus vaccine candidate this year to decide whether it is effective enough to ...

BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced a transaction in which Advantech ...